Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immune IQ is a private healthcare diagnostics and medtech company developing point-of-care diagnostic systems that read signals from the human immune system to rapidly identify disease. The company is best known for its Immune Reveal platform, described as a point-of-care flow cytometry-based system that combines immune-system data generation with artificial intelligence-driven analysis. Its stated focus is rapid multi-disease detection in acute and critical care settings, with applications that have included sepsis, cardiovascular disease, cancer, COVID-19, and broader infectious disease use cases. Immune IQ appears to have evolved from or rebranded an earlier entity known as Ativa Medical, while maintaining continuity in leadership and mission. The company is privately funded and based in Minnesota.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immune IQ.